Amp Human is proud to be expanding large employer access to rapid antibody test kits through a partnership with Arizona-based BioLab Sciences.
Antibody testing is expected to quickly become the standard method for employers to know who among their workforce may have been exposed to the virus (whether they showed symptoms or not) and gain some assurance whether employees are safe to return to work. Individuals who have developed antibodies but don’t have the type that would indicate current infection are thought to be the most eligible to be in highly interactive roles in the workplace during the coronavirus crisis due to their immunity that antibodies imply and their lesser likelihood to infect others.
BioLab Sciences’ antibody kit is an instant finger prick screening tool that displays results within 10 minutes for two antibodies (IgM and IgG), one that indicates past exposure to the virus and one that screens for current infection. Rapid COVID-19 antibody test kits are point of care screening tools meaning that they require a mid-level practitioner or above to interpret the results.
Amp Human is helping BioLab Sciences quickly scale kit availability by connecting them with large essential employers. The supply of antibody test kits faces two challenges: (1) kits with poor reliability and accuracy are flooding in from abroad and (2) at-scale manufacturing is lacking among reliable kit makers. BioLab Sciences solves both of these challenges by producing high accuracy kits in the USA and Europe and in the millions of units a week.
If antibody testing is relevant for you or your workforce, don't hesitate to reach out to Amp Human at email@example.com our through the contact information in the summary sheet. We look forward to doing our part in expanding access to this vital resource that will be pivotal in bringing Americans back to work.